Diseases & Disorders
(G810)
IRS Verified
DX Registered
990 on File
CHASE BREXTON HEALTH SERVICES INC
Financial strength (30%)
81/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$172.8M
Total Revenue
$165.2M
Total Expenses
$126.4M
Net Assets
696
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.5%
Fundraising Efficiency
10892.8%
Operating Reserve
9.18x
Liability-to-Asset
17.2%
Revenue Diversification
91.5%
Executive Compensation
$2.0M
Compared with Peers
FY 2025
Compared with 21 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.5% | 83.9% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
16.1% | 8.8% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.4% | 0.8% |
P10P90
|
Above median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
10892.8% | 512.7% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.2 mo | 8.2 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
17.2% | 31.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.5% | 94.4% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
8.2% | 8.2% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.4% | 7.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
4.4% | 0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $172.8M | $165.2M | $126.4M | 83.5% | 696 |
| 2024 | $159.7M | $153.8M | $112.5M | 83.1% | 653 |
| 2023 | $144.4M | $135.4M | $98.5M | 81.9% | 579 |
| 2022 | $143.5M | $125.9M | $84.4M | 82.8% | 575 |
| 2021 | $148.3M | $122.5M | N/A | — | 525 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.